Researchers say they have identified 4 subtypes of prostate cancer with distinct biological and clinical features, and these subtypes may respond differently to treatment.
A recent study found a racial disparity in the use of guideline-concordant treatment for metastatic prostate cancer.
Clinician-led discussion of PSA testing advantages was associated with overscreening among older men.
Pluvicto is indicated for patients with PSMA-positive metastatic castration-resistant prostate cancer who have been treated with AR pathway inhibition and taxane-based chemotherapy.
Dietary counseling may improve clinical outcomes for men with prostate cancer.
Prostate cancer has one of the largest racial disparities in outcomes between Black and White patients, according to investigators.
A report from the American Cancer Society reveals trends in cancer incidence and mortality over time and includes projections for 2023.
Incidence and mortality rates for major genitourinary cancers differ according to sex, race/ethnicity, and geographic region.
Radiation therapy for prostate cancer is significantly associated with more than twice the risk for bladder cancer compared with radical prostatectomy, a study found.
Roughly half of hospitals accredited by the ACS-CoC failed to disclose the cost of 5 common cancer surgeries, researchers found.
